University of Birmingham

Academic Institute

Anuradhaa Subramanian - Chief Investigator - University of BirminghamAnuradhaa Subramanian - Corresponding Applicant - University of BirminghamAstha Anand - Collaborator - University of BirminghamKrishna Gokhale - Collaborator - University of BirminghamKrishnarajah Nirantharakumar - Collaborator - University of BirminghamSiang Ing Lee - Collaborator - University of BirminghamTom Taverner - Collaborator - University of Birmingham

CPRD254

Polycystic ovarian syndrome (PCOS) has long been considered as a reproductive disorder. In the wake of new findings, PCOS is now identified as a metabolic disorder that affects women throughout their lifetime, and even posing intergenerational risks to their children. These risks maybe attributed to several elements of PCOS– (1) underlying androgen excess, i-e, high levels of “male” hormone, (2) insulin resistance, a driver to the development of type 2 diabetes, (3) other co-morbidities that are commonly seen among women with PCOS, and (4) drugs prescribed to them.

The aim of this study is to estimate the trends in incidence and prevalence of PCOS within the primary care setting and to understand the PCOS disease burden, especially among pregnant women.

27/04/2021

Release